Form 8-K - Current report:
SEC Accession No. 0001279569-09-001449
Filing Date
2009-11-16
Accepted
2009-11-13 18:10:43
Documents
2
Period of Report
2009-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nucryst8k.htm 8-K 23651
2 NEWS RELEASE DATED NOVEMBER 13, 2009 ex991.htm EX-99.1 13801
  Complete submission text file 0001279569-09-001449.txt   38980
Mailing Address 101 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 101 COLLEGE ROAD EAST PRINCETON NJ 08540 609-228-8210
NUCRYST Pharmaceuticals Corp. (Filer) CIK: 0001344674 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51686 | Film No.: 091183040
SIC: 3841 Surgical & Medical Instruments & Apparatus